These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11363363)

  • 1. Nevirapine expanded access.
    Posit Aware; 1996; 7(2):5. PubMed ID: 11363363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nevirapine approval expands combo possibilities--and HIV suppression.
    Vazquez E
    Posit Aware; 1996; 7(5):9. PubMed ID: 11363791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine receives green light from Health Protection Branch.
    TreatmentUpdate; 1998 Oct; 10(8):4-5. PubMed ID: 11365878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA approves first new class of HIV drugs. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine, the first of a new class of NNRTI drugs arrives in pharmacies.
    Crit Path AIDS Proj; 1996; (No 31):18-9. PubMed ID: 11363827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevirapine recommended for approval.
    BETA; 1996 Jun; ():6-7. PubMed ID: 11363650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine surprise.
    Smart T
    GMHC Treat Issues; 1996; 10(6/7):25. PubMed ID: 11363640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viramune Expanded Access Program begins.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361629
    [No Abstract]   [Full Text] [Related]  

  • 9. Viramune (Nevirapine) is approved for children.
    Vazquez E
    Posit Aware; 1998; 9(6):17. PubMed ID: 11366470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine--first of a new class of drugs.
    PI Perspect; 1996 Sep; (No 19):9-10. PubMed ID: 11363907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nevirapine approved by FDA. Food and Drug Administration.
    Bowersox J
    NIAID AIDS Agenda; 1996 Sep; ():10. PubMed ID: 11363918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA news. Food and Drug Administration.
    Res Initiat Treat Action; 1999 Jan; 5(1):20. PubMed ID: 11366229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nucleoside reverse transcriptase inhibitors.
    Bowers M
    BETA; 1996 Jun; ():19-22. PubMed ID: 11363645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New non-nucleoside reverse transcriptase inhibitor.
    Smart T; Torres G
    GMHC Treat Issues; 1995; 9(7/8):10. PubMed ID: 11362651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on nevirapine: quest for a niche.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):37-43. PubMed ID: 11364713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New combination medications].
    Agosto M
    Sidahora; 1997; ():43-6. PubMed ID: 11364501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delavirdine (Rescriptor) approved.
    James JS
    AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA notifications. NRTI Emtriva receives FDA approval.
    AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA notifications. Tentative approval granted of generic nevirapine.
    AIDS Alert; 2007 Sep; 22(9):104-5. PubMed ID: 18415956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.